TCM Composition Inhibits Tumor Growth via Immune Surveillance
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for malignant tumors, such as surgery, radiation therapy, and chemotherapy, have limitations and adverse effects on normal tissues and immune systems, and there is a need for a more effective method to improve the tumor microenvironment and enhance immune surveillance.
Innovation Solution
A traditional Chinese medicine composition comprising GANODERMA polysaccharide, GRIFOLA FRONDOSA polysaccharide, ANGELICAE SINENSIS RADIX oil, and CINNAMOMI CORTEX oil, with specific extraction methods, which is formulated to inhibit tumor growth, increase CD4+ and CD8+ cells, decrease VEGF and TGF-β 1 positive cells, and restore normal immune function.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If surgery, radiation therapy, or chemotherapy is used to treat malignant tumors, then tumor growth is inhibited or removed, but normal immune system function is suppressed and adverse effects on normal tissues occur
Solution Approach 1:
The patent divides the treatment approach into multiple functional components: polysaccharides from different medicinal materials (Lentinus edodes, Grifola frondosa, Cordyceps sinensis) each contribute specific immune-modulating activities, while essential oils provide complementary anti-tumor effects. This segmented approach allows each component to target specific aspects of tumor immunity without the broad suppression caused by conventional therapies.
Solution Approach 2:
The patent creates a composite medicinal composition combining four distinct natural substances: Lentinus edodes polysaccharide, Grifola frondosa polysaccharide, Cordyceps sinensis polysaccharide, and essential oils from Angelica sinensis and Cinnamomum cassia. This composite formulation synergistically enhances immune surveillance and anti-tumor activity while reducing individual component dosages and associated side effects.
2Productivity
If conventional tumor treatments are applied, then tumor cells are destroyed or growth is inhibited, but the tumor microenvironment remains immunosuppressive and immune surveillance is impaired
Solution Approach 1:
The patent introduces polysaccharides from medicinal mushrooms and caterpillar fungus as intermediary substances that mediate between the immune system and tumor cells. These polysaccharides act as immunomodulators that enhance the activity of immune effector cells (NK cells, CD8+ T cells) and reduce suppressor cell activity, thereby restoring immune surveillance without directly attacking tumor cells.
Solution Approach 2:
The patent changes the immunological parameters of the tumor microenvironment by increasing the ratio of effector cells to suppressor cells, enhancing cytokine production (IFN-γ, TNF-α), and modifying the functional state of immune cells. This parameter transformation shifts the microenvironment from immunosuppressive to immunostimulatory, enabling effective immune surveillance.
3Productivity
If high doses of radiation or chemotherapy are used to maximize tumor killing, then tumor growth inhibition improves, but damage to normal tissues and immune suppression worsen
Solution Approach 1:
The patent applies partial action by using moderate doses of each natural component rather than maximum doses of single conventional therapies. The combination of four substances at optimized ratios achieves cumulative anti-tumor effects equivalent to or exceeding high-dose conventional treatments, while each individual component remains below toxic thresholds.
Solution Approach 2:
The patent converts the traditionally harmful approach of high-dose monotherapy into a beneficial multi-component strategy. By distributing the therapeutic burden across four natural substances with different mechanisms of action, the treatment achieves superior tumor control while converting potential toxicity into a synergistic therapeutic effect that protects normal tissues.
Data Source
AI summary
The present disclosure relates to the field of drugs and health foods. Disclosed is a traditional Chinese medicine composition comprising GANODERMA polysaccharide, GRIFOLA FRONDOSA polysaccharide, ANGELICAE SINENSIS RADIX oil and CINNAMOMI CORTEX oil. Experiments show that the traditional Chinese medicine composition has a scientific formulation, synergistic functions, without toxic and side effects, and not only has nutritional value but also inhibits the growth of tumor. Comparing with individual components, the composition significantly increases the percentages of CD4+ and CD8+ cells in lymphocytes of the tumor stroma, increases body immune function, recovers normal immune surveillance function, decreases the expression rate of VEGF and TGF-β 1 positive cells in tumor tissue, assists in treating tumor, increases antitumor effects of chemotherapy drugs, improves immune status of body, has the function of restoring normal immune surveillance, preventing and assisting in treating tumor.